Finance

Beta
Lists
CTMX:NASDAQ
CytomX Therapeutics Inc
$3.00
-5.66%
(-0.18) 1D
$3.02
+0.67% (+0.020)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTMX...
Open
$3.19
High
$3.19
Low
$2.98
Mkt. cap
653.11M
Avg. vol.
3.28M
Volume
3.42M
52-wk high
$8.20
52-wk low
$1.72
EPS
-$0.36
Beta
2.08
Shares outstanding
217.70M
No. of employees
69
Open
$3.19
High
$3.19
Low
$2.98
Mkt. cap
653.11M
Avg. vol.
3.28M
Volume
3.42M
52-wk high
$8.20
52-wk low
$1.72
EPS
-$0.36
Beta
2.08
Shares outstanding
217.70M
No. of employees
69
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to CTMX in the past 3 months
Strong Buy
Buy
10
Hold
0
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CTMX in the last 3 months.
Highest
Current $3.00
$16.00 (+433.33%)
Average
$12.30 (+310.00%)
Lowest
$6.00 (+100.00%)
News stories
From sources across the web
About CytomX Therapeutics Inc
CEO-
Employees69
Founded2008
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytomx.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.10 / -$0.12
+16.26%beat
Revenue / Est. (USD)
10.26M / 3.92M
+161.46%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.66M
5.96M
663.00K
10.26M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13.32M
15.30M
19.54M
19.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.62M
6.43M
6.26M
10.69M
Operating expense
19.94M
21.73M
25.80M
29.93M
Total operating expenses
19.94M
21.73M
25.80M
29.93M
Operating income
-1.29M
-15.77M
-25.13M
-19.67M
Other non operating income
-
-
-
-
EBT including unusual items
-91.00K
-14.17M
-26.46M
-18.19M
EBT excluding unusual items
-91.00K
-14.17M
-23.66M
-18.19M
Income tax expense
63.00K
58.00K
54.00K
59.00K
Effective tax rate
-69.23%
-0.41%
-0.20%
-0.32%
Other operating expenses
-
-
-
-
Net income
-154.00K
-14.23M
-26.51M
-18.25M
Net profit margin
-0.83%
-238.62%
-3,998.49%
-177.89%
Earnings per share
-
-0.09
-0.22
-0.10
Interest and investment income
1.18M
1.59M
1.48M
1.49M
Interest expense
-
-
-
-
Net interest expenses
1.18M
1.59M
1.48M
1.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-939.00K
-15.63M
-24.62M
-19.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer